You join us for the fourth in our weekly blogs dedicated to taking an accessible look at Multifocal Motor Neuropathy - or MMN. In previous editions, we've looked at what MMN is, the common MMN symptoms, and how you might expect MMN to be diagnosed. So what happens when someone finally gets a diagnosis of MMN? What does treatment look like? Can it be treated? Can it be cured? Let's start with - can it be cured? The short answer is, no. There is no current cure for MMN at the

You join us for our third in our series of accessible, bite sized blogs all about MMN. In week one, we took a general overview of the condition, and last week we investigated some of MMN's classic symptoms and warning signs. This week, let's look at what happens next. Misdiagnosis and Timeline We'll be honest, this part is hard. Officially, your time to diagnosis should be around one to two years. However - and it's important we say this is anecdotal from conversations with

Last week we took a look into MMN as a whole - what is this rare condition? What does diagnosis and treatment look like? And of course, what are the symptoms of MMN? This week, we're diving into that last question in a little more detail. We'll look at some of the early signs, and key symptoms you should look out for.  Early Signs of MMN MMN often starts subtly, which makes it easy to miss in the early stages. Many people later diagnosed with the condition noticed a weakness

As February is MMN Awareness Month, it is time to not just shine a light on MMN, but also on ourselves about how we support people impacted by MMN. 

Multifocal Motor Neuropathy , or MMN for short, is a rare, life-long condition that affects the motor nerves, which control muscle movement. This leads to muscle weakness, often starting in the hands or arms. MMN is very rare, impacting 0.6 people per 100,000. Anyone can get MMN, but it is more common in older men than women. However, we have met people from all walks of life living with the condition. MMN is not infectious, meaning you can't pass it along to anyone else. Cau

If you're living with GBS, CIDP, MMN, or another Inflammatory Neuropathy, you may have questions about how today's budget impacts you. Are you having trouble getting your head around what was said, or just fancy a quick summary of the key points? Well, if so, our Chief Executive is here with his traditional reflection on the budget and what it means for people impacted by Inflammatory Neuropathies, and for the charity itself.    To be honest, there wasn’t a great deal of ant